Penile foreskin is immunologically complete: raises new vaccine possibilities for HIV vaccine

July 23, 2012, American Society for Microbiology

Rhesus macaque monkeys infected with simian immunodeficiency virus (SIV) harbor immunoglobulin G (IgG) and SIV-specific antibodies and T cells in the foreskin of the penis, according to a study in the July 2012 Journal of Virology. This is the first time antibody secreting cells, antiviral antibodies or antiviral T cells have been reported in the foreskin of any primate.

Although "it has been known for some time that there was a population of in the surfaces of the human penis, and in all skin, for that matter, the potential functions of these cells, especially with regard to anti-HIV activity, had never been determined," says principal investigator Christopher J. Miller of the University of California, Davis. The new finding, he says, could lead to vaccine strategies designed to elicit HIV-specific immunity in the foreskin.

Cells which are targets of HIV are present in multiple epithelial tissues of the penis, and the foreskin—the skin of the penis that is lost during circumcision—is thought to be an especially important route of HIV transmission. "…the presence of an intact foreskin is associated with an approximately 50 percent increased risk of HIV acquisition," the researchers write, citing seven studies. Although HIV-specific antibodies and are present in semen of HIV-infected humans, very little research has investigated mucosal immune responses of the surface of the penis, says Miller.

Male rhesus macaques are good models for the human reproductive system immunity. "…based on histology, there is no difference in the numbers or locations of CD4+ cells in the inner and outer foreskin of adult [rhesus macaques] or men," according to the report. "In addition to CD4+ T cells, the foreskin and glans of the human penis have a complete population of immune cells, but antigen-specific immune responses in these tissues have not been described [until now]," says Miller.

Miller's lab was also the first to report antiviral T cells in the female genital tract, research which led to efforts to develop vaccines that could elicit anti-HIV immunity in the female reproductive tract.

Explore further: New memory for HIV patients

More information: K. Rothaeusler, Z.-M. Ma, H. Qureshi, T.D. Carroll, T. Rourke, M.B. McChesney, and C.J. Miller, 2012. Antiviral antibodies and T cells are present in the foreskin of simian immunodeficiency virus-infected rhesus macaques. Journal of Virology 86:7098-7106.

Related Stories

New memory for HIV patients

March 26, 2012
The hallmark loss of helper CD4+ T cells during human immunodeficiency virus (HIV) infection may be a red herring for therapeutics, according to a study published on March 26th in the Journal of Experimental Medicine.

Immune cells in the gut may improve control of HIV growth

June 11, 2012
The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing ...

Researchers identify potential new HIV vaccine/therapy target

May 30, 2012
After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.